Detalhe da pesquisa
1.
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
JAMA
; 329(18): 1567-1578, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37159034
2.
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis.
ERJ Open Res
; 10(1)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38288082
3.
Randomized Double-Blind Controlled Trial of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 196(5): 656-659, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146642
4.
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis.
Arthritis Rheumatol
; 75(8): 1434-1444, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787101
5.
Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study.
Respirology
; 17(2): 379-89, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22122202
6.
Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study.
BMC Pulm Med
; 10: 11, 2010 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211002
7.
Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 µg/day.
J Asthma Allergy
; 10: 35-46, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331346
8.
Chronic obstructive pulmonary disease in China: the potential role of indacaterol.
J Thorac Dis
; 5(4): 549-58, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991315
9.
Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population.
Respir Med
; 106(12): 1715-21, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23040786